UK project aims to enhance the detection and early diagnosis of breast cancer

News

A project designed to enhance the detection and early diagnosis of breast cancer whilst bringing down costs to health service providers is set to begin in Newcastle.

breast cancer

Funded with £1.4m from Innovate UK, the three-year programme will see Kromek, a Sedgefield-headquartered developer of radiation detection technologies, partner with Newcastle-upon-Tyne Hospitals NHS Foundation Trust to deliver a Low Dose Molecular Breast Imaging (LDMBI) technology.

The LDMBI will be based on Kromek’s CZT-based (Cadmium Zinc Telluride) SPECT (Single Photon Emission Computed Tomography) detectors.

In the first phase of the project, Kromek will utilise new developments in the company’s CZT-based SPECT detector technology to reduce the required dose of radiation in molecular breast imaging, a technology which uses a radioactive tracer to identify tumours.

In this imaging technique, the tracer is said to concentrate more in malignant breast tissue, allowing the tumour to be easily identified irrespective of breast density. By partnering with breast cancer experts at the Newcastle Hospitals for the development, the team will ensure that the technology is tuned to clinical and patient needs.

Register now to continue reading

Thanks for visiting The Engineer. You’ve now reached your monthly limit of news stories. Register for free to unlock unlimited access to all of our news coverage, as well as premium content including opinion, in-depth features and special reports.  

Benefits of registering

  • In-depth insights and coverage of key emerging trends

  • Unrestricted access to special reports throughout the year

  • Daily technology news delivered straight to your inbox

Register
Or continue by

Signing in with your registered email address